StockDrifts LogoStockDrifts

Nea Management Company 13F Portfolio

Portfolio Manager
Nea Management Company LLC
Performance
+16.54% (2026 Q2)
AUM (13F)
$1.59B
# of Holdings
26
Performance Rank
Allocation (Top 20)
99.14%
Latest filing
Q2 2026

Nea Management Company LLC Holdings Map

Top 26 Nea Management Company LLC Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
TRVI
Trevi Therapeutics, Inc.
15.53%13.22M$246.6M
+0.00%(+0)
2025-Q2: 13.22M shares2025-Q3: 13.22M shares2025-Q4: 13.22M shares2026-Q1: 13.22M shares2026-Q2: 13.22M shares
$3.07(+500.34%)
2026-06-30
MBX
MBX Biosciences, Inc.
12.56%3.61M$199.5M
+0.00%(+0)
2025-Q2: 3.61M shares2025-Q3: 3.61M shares2025-Q4: 3.61M shares2026-Q1: 3.61M shares2026-Q2: 3.61M shares
$25.98(+163.93%)
2026-06-30
GLUE
Monte Rosa Therapeutics, Inc.
11.72%7.69M$186.2M
+0.00%(+0)
2025-Q2: 7.69M shares2025-Q3: 7.69M shares2025-Q4: 7.69M shares2026-Q1: 7.69M shares2026-Q2: 7.69M shares
$22.70(-31.72%)
2026-06-30
CELC
Celcuity Inc.
11.27%1.71M$179.0M
-25.16%(-575.00K)
2025-Q2: 2.29M shares2025-Q3: 2.14M shares2025-Q4: 3.54M shares2026-Q1: 2.29M shares2026-Q2: 1.71M shares
$36.57(+151.55%)
2026-06-30
SGP
Spyglass Pharma, Inc.
10.36%7.39M$164.6M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 7.39M shares2026-Q2: 7.39M shares
$25.91(+1.12%)
2026-06-30
SVRA
Savara, Inc.
9.49%24.47M$150.7M
+0.00%(+0)
2025-Q2: 24.47M shares2025-Q3: 24.47M shares2025-Q4: 24.47M shares2026-Q1: 24.47M shares2026-Q2: 24.47M shares
$1.64(+227.95%)
2026-06-30
ZBIO
Zenas BioPharma, Inc.
6.43%4.02M$102.1M
+0.00%(+0)
2025-Q2: 2.73M shares2025-Q3: 2.73M shares2025-Q4: 3.52M shares2026-Q1: 4.02M shares2026-Q2: 4.02M shares
$20.47(+44.16%)
2026-06-30
COUR
Coursera, Inc.
4.57%12.87M$72.6M
+0.00%(+0)
2025-Q2: 12.87M shares2025-Q3: 12.87M shares2025-Q4: 12.87M shares2026-Q1: 12.87M shares2026-Q2: 12.87M shares
$45.00(-87.16%)
2026-06-30
AUPH
Aurinia Pharmaceuticals, Inc.
4.24%3.97M$67.4M
+0.00%(+0)
2025-Q2: 3.97M shares2025-Q3: 3.97M shares2025-Q4: 3.97M shares2026-Q1: 3.97M shares2026-Q2: 3.97M shares
$6.68(+131.57%)
2026-06-30
CRSP
CRISPR Therapeutics AG
3.64%1.06M$57.7M
+0.00%(+0)
2025-Q2: 1.59M shares2025-Q3: 1.06M shares2025-Q4: 1.06M shares2026-Q1: 1.06M shares2026-Q2: 1.06M shares
$22.19(+141.37%)
2026-06-30

About Nea Management Company LLCโ€™s portfolio

Nea Management Company LLC reports $1.59B in US-listed equity holdings across 26 positions in its most recent 13F filing. Its largest disclosed positions are TRVI (15.5%), MBX (12.6%) and GLUE (11.7%). The top 20 holdings account for 99.14% of reported assets. Its disclosed equity book has returned +123.52% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
TRVI โ€” 15.5% ($246.59M)MBX โ€” 12.6% ($199.52M)GLUE โ€” 11.7% ($186.15M)CELC โ€” 11.3% ($178.96M)SGP โ€” 10.4% ($164.55M)SVRA โ€” 9.5% ($150.74M)ZBIO โ€” 6.4% ($102.11M)COUR โ€” 4.6% ($72.57M)AUPH โ€” 4.2% ($67.37M)CRSP โ€” 3.6% ($57.73M)Other โ€” 10.2% ($161.63M)
90%in top 10
  • TRVI15.5%
  • MBX12.6%
  • GLUE11.7%
  • CELC11.3%
  • SGP10.4%
  • SVRA9.5%
  • ZBIO6.4%
  • COUR4.6%
  • AUPH4.2%
  • CRSP3.6%
  • Other10.2%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
1
KPTIKaryopharm Therapeutics Inc.0.3%
Trimmed
2
CELCCelcuity Inc.-25.2%
CVRXCVRx, Inc.-3.5%

Unlock alerts, watchlists & AI chat

Sign up free to track Nea Management Company LLC, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Nea Management Company LLCโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1512848). View Nea Management Company LLCโ€™s 13F filings on SEC

More 13F analyses

View all